Faculty, Staff and Student Publications
Language
English
Publication Date
11-25-2025
Journal
Discover Oncology
DOI
10.1007/s12672-025-03896-z
PMID
41288848
PMCID
PMC12647442
PubMedCentral® Posted Date
11-25-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Background: Previous studies have reported excellent disease control and survival in patients with well-lateralized, American Joint Committee on Cancer (AJCC)-7 T1-2N2b tonsillar squamous cell carcinoma (SCC). The reduced treatment volume is associated with lower rates of physician-assessed toxicity. Patient-reported outcomes (PROs) have been proposed as a similarly reliable measure, but the body of literature is limited for unilaterally treated patients. Our goal was to review PROs of such patients who had reduced treatment volumes.
Methods: We reviewed PROs of patients with AJCC-7 T1-2N2b disease treated with ipsilateral radiation therapy (RT), with or without surgery or chemotherapy before RT. PROs were measured using the MD Anderson Symptom Inventory for head and neck cancer after a median of 28.9 months.
Results: Forty-eight patients were included in the study: 36 (75%) had human papillomavirus-positive disease, 20 (42%) had ≥ 2 nodal levels involved, 15 (31%) had extranodal extension and all patients had N2b disease. Most patients reported no symptoms; a median 72.9% for all 10 head-and-neck symptoms, 75.0% for all 12 core symptoms, and 83.3% for all 6 interference symptoms reported a score of “0”. The most common head-and-neck and core symptoms were dry mouth (n = 33, 69%) and fatigue (n = 23, 48%). Treatment mostly interfered with general activities. PROs were not affected by receipt of surgery; however, receipt of systemic therapy was associated with worse general activity (P = 0.044). Longitudinal analyses revealed mildly worse dry mouth (from 0 of 10 points to 1.5 of 10, P = 0.012) and numbness/tingling (from 0 of 10 to 0.5 of 10, P = 0.020).
Conclusions: Ipsilateral neck RT for N2b tonsil SCC was associated with only a mild PRO symptom burden after at least 18 months, and therefore, a well-tolerated toxicity reduction strategy for appropriate patients.
Keywords
PRO, Toxicity, Unilateral radiation therapy, MDASI, MDADI, MD Anderson symptom inventory for head and neck, HPV, Xerostomia
Published Open-Access
yes
Recommended Citation
Abana, Chike O; Garden, Adam S; Brandon Gunn, G; et al., "Patient-Reported Outcomes After Ipsilateral Radiation Therapy for N2b Tonsillar Squamous Cell Carcinoma" (2025). Faculty, Staff and Student Publications. 5666.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5666
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons